White matter DNA methylation profiling reveals deregulation of HIP1, LMAN2, MOBP, and other loci in multiple system atrophy

Acta Neuropathol. 2020 Jan;139(1):135-156. doi: 10.1007/s00401-019-02074-0. Epub 2019 Sep 18.

Abstract

Multiple system atrophy (MSA) is a fatal late-onset neurodegenerative disease. Although presenting with distinct pathological hallmarks, which in MSA consist of glial cytoplasmic inclusions (GCIs) containing fibrillar α-synuclein in oligodendrocytes, both MSA and Parkinson's disease are α-synucleinopathies. Pathologically, MSA can be categorized into striatonigral degeneration (SND), olivopontocerebellar atrophy (OPCA) or mixed subtypes. Despite extensive research, the regional vulnerability of the brain to MSA pathology remains poorly understood. Genetic, epigenetic and environmental factors have been proposed to explain which brain regions are affected by MSA, and to what extent. Here, we explored for the first time epigenetic changes in post-mortem brain tissue from MSA cases. We conducted a case-control study, and profiled DNA methylation in white mater from three brain regions characterized by severe-to-mild GCIs burden in the MSA mixed subtype (cerebellum, frontal lobe and occipital lobe). Our genome-wide approach using Illumina MethylationEPIC arrays and a powerful cross-region analysis identified 157 CpG sites and 79 genomic regions where DNA methylation was significantly altered in the MSA mixed-subtype cases. HIP1, LMAN2 and MOBP were amongst the most differentially methylated loci. We replicated these findings in an independent cohort and further demonstrated that DNA methylation profiles were perturbed in MSA mixed subtype, and also to variable degrees in the other pathological subtypes (OPCA and SND). Finally, our co-methylation network analysis revealed several molecular signatures (modules) significantly associated with MSA (disease status and pathological subtypes), and with neurodegeneration in the cerebellum. Importantly, the co-methylation module having the strongest association with MSA included a CpG in SNCA, the gene encoding α-synuclein. Altogether, our results provide the first evidence for DNA methylation changes contributing to the molecular processes altered in MSA, some of which are shared with other neurodegenerative diseases, and highlight potential novel routes for diagnosis and therapeutic interventions.

Keywords: Brain tissue; EWAS; MSA; Neurodegeneration; Pathological subtypes; WGCNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Brain / metabolism
  • Brain / pathology
  • Case-Control Studies
  • DNA Methylation / genetics*
  • DNA-Binding Proteins / genetics*
  • Female
  • Gene Expression Profiling
  • Humans
  • Male
  • Mannose-Binding Lectins / genetics*
  • Membrane Transport Proteins / genetics*
  • Middle Aged
  • Multiple System Atrophy / genetics*
  • Multiple System Atrophy / pathology
  • Myelin Proteins / genetics*
  • White Matter / metabolism
  • White Matter / pathology
  • alpha-Synuclein / genetics

Substances

  • DNA-Binding Proteins
  • HIP1 protein, human
  • LMAN2 protein, human
  • MOBP protein, human
  • Mannose-Binding Lectins
  • Membrane Transport Proteins
  • Myelin Proteins
  • SNCA protein, human
  • alpha-Synuclein